Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Elon Musk - not Twitter -- ONCY
View:
Post by SundayMovies on Dec 19, 2022 12:36pm

Elon Musk - not Twitter -- ONCY

Twitter purchase was a joke. Elon paid 44 billion for it.

And you don't think 1billion valuation for ONCY is possible???!!!
Crypto market is what 1 trillion  or more.

And you don't think 1billion valuation for ONCY is possible. 

I say this is not a dream here. It's more real than crypto zeros and less twit than Twitter
Comment by TitanBrawler on Dec 19, 2022 12:56pm
Well said,  But who is going to pay billions for a product  product doesn't work . Not even musk is that stupid.  
Comment by SundayMovies on Dec 19, 2022 1:09pm
Once the data is final and peer reviewed, it will be considered to be "working" The first time I see such strong interim data + signs of imminent deal (90 days review period) in a Biotech.  You can't have more reassurance then this... This stock is undervalued, sad to see that traders are not pushing it aggressively higher. Eventually, this trade/investment will pay off ...more  
Comment by Buckhenry on Dec 19, 2022 1:44pm
is Elon buying oncy.....woowho....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities